Search Results - "Oigman, Willie"

Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension by White, William B, Littlejohn, Thomas W, Majul, Claudio R, Oigman, Willie, Olvera, Rafael, Seeber, Mary, Schumacher, Helmut, Mancia, Giuseppe

“…Evaluation of combination therapy with antihypertensive agents by clinic blood pressure (BP) measurements may yield results that differ from out-of-office BP…”
Get full text

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial: Outcomes in Patients Receiving Monotherapy by Julius, Stevo, Weber, Michael A, Kjeldsen, Sverre E, McInnes, Gordon T, Zanchetti, Alberto, Brunner, Hans R, Laragh, John, Schork, M Anthony, Hua, Tsushung A, Amerena, John, Balazovjech, Ivan, Cassel, Graham, Herczeg, Bela, Koylan, Nevres, Magometschnigg, Dieter, Majahalme, Silja, Martinez, Felipe, Oigman, Willie, Gomes, Ricardo Seabra, Zhu, Jun-ren

“…In the main Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) report, we investigated outcomes in 15 245 high-risk hypertensive subjects treated with…”
Get full text

Evidence for the efficacy of ARBs across the cardiovascular continuum by Gupta, Milan, Honos, George N., Velazquez, Eric J., Chung, Namsik, Oigman, Willie, Maggioni, Aldo P.

“…Abstract Introduction: Angiotensin II receptor blockers (ARBs) are antihypertensive agents with considerable evidence of efficacy and safety for the reduction…”
Get full text

The valsartan antihypertensive long-term use evaluation (VALUE) trial : Outcomes in patients receiving monotherapy. Commentary by SICA, Domenic A, JULIUS, Stevo, AMERENA, John, BALAZOVJECH, Ivan, CASSEL, Graham, HERCZEG, Bela, KOYLAN, Nevres, MAGOMETSCHNIGG, Dieter, MAJAHALME, Silja, MARTINEZ, Felipe, OIGMAN, Willie, GOMES, Ricardo Seabra, WEBER, Michael A, ZHU, Jun-Ren, KJELDSEN, Sverre E, MCLNNES, Gordon T, ZANCHETTI, Alberto, BRUNNER, Hans R, LARAGH, John, SCHORK, M. Anthony, HUA, Tsushung A

Get full text

Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: Favorable hemodynamics and pharmacokinetics by Bursztyn, Michael, Kadr, Honer, Tilvis, Reijo, Martina, Benedict, Oigman, Willie, Talberg, Jonas, Kobrin, Isaac

“…A multicenter, double-blind, placebo-controlled study of 310 elderly patients with mild-to-moderate essential hypertension was conducted in 20 sites throughout…”
Get full text

Diurnal variation of blood pressure in elderly patients with essential hypertension by Kobrin, I, Oigman, W, Kumar, A, Ventura, H O, Messerli, F H, Frohlich, E D, Dunn, F G

“…Twenty-one elderly patients with essential hypertension, all over 65 years of age, were subjected to automated noninvasive 24-hour blood pressure measurement…”
Get more information

Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension by Ventura, Hector O., Messerli, Franz H., Oigman, Willie, Dunn, Francis G., Reisin, Efrain, Frohlich, Edward D.

“…The immediate hemodynamic effects of a new calcium-channel blocking agent nitrendipine were studied in 12 patients with mild established essential…”
Get full text

Hemodynamic effects of intravenous labetalol in essential hypertension by Dunn, F G, Oigman, W, Messerli, F H, Dreslinski, G R, Reisin, E, Frohlich, E D

“…Labetalol inhibits alpha- and beta-adrenergic receptors. Systemic and regional hemodynamic alterations after intravenous labetalol and its cardiovascular…”
Get more information